Acorah Software Products - Accounts Production 19.4.351 false true 31 January 2025 1 February 2024 false true No description of principal activity 1 February 2025 31 January 2026 31 January 2026 14604594 Mr Jasjeet Sethi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14604594 2025-01-31 14604594 2026-01-31 14604594 2025-02-01 2026-01-31 14604594 frs-core:CurrentFinancialInstruments 2026-01-31 14604594 frs-bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 14604594 frs-bus:FilletedAccounts 2025-02-01 2026-01-31 14604594 frs-bus:Micro-entities 2025-02-01 2026-01-31 14604594 frs-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 14604594 frs-bus:Director1 2025-02-01 2026-01-31 14604594 2024-01-31 14604594 2025-01-31 14604594 2024-02-01 2025-01-31 14604594 frs-core:CurrentFinancialInstruments 2025-01-31
Registered number: 14604594
JS Pharma London Ltd
Unaudited Financial Statements
For The Year Ended 31 January 2026
DRP Partners Ltd
Balance Sheet
Registered number: 14604594
2026 2025
£ £
Fixed assets - 944
Current assets 264 1,026
Creditors: Amounts Falling Due Within One Year - (378 )
NET CURRENT ASSETS 264 648
TOTAL ASSETS LESS CURRENT LIABILITIES 264 1,592
Accruals and deferred income - (384 )
NET ASSETS 264 1,208
CAPITAL AND RESERVES 264 1,208

Notes

1. General Information
JS Pharma London Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14604594 . The registered office is 1 Red Campion Grove, Cliffe Woods, Rochester, ME3 8QZ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2025: NIL)
- -
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Jasjeet Sethi
Director
27/10/2026